IL1RL1 and neoplasm: In contrast to the tumor promoting effects of IL-33/ST2 signaling described above, shRNA mediated knockdown of ST2 in murine CT26 cells enhanced tumor growth in Balb/c mice suggesting an anti-tumorigenic role in CRC [47].